Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
Cyclin-dependent kinase inhibitors (CKIs) and Notch receptor activation have been shown to influence adult stem cells and progenitors by altering stem cell self-renewal and proliferation. Yet, no interaction between these molecular pathways has been defined. Here we show that ligand-independent and...
Saved in:
Published in: | The Journal of experimental medicine Vol. 202; no. 1; pp. 157 - 168 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
The Rockefeller University Press
04-07-2005
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cyclin-dependent kinase inhibitors (CKIs) and Notch receptor activation have been shown to influence adult stem cells and progenitors by altering stem cell self-renewal and proliferation. Yet, no interaction between these molecular pathways has been defined. Here we show that ligand-independent and ligand-dependent activation of Notch1 induces transcription of the S phase kinase–associated protein 2 (SKP2), the F-box subunit of the ubiquitin-ligase complex SCFSKP2 that targets proteins for degradation. Up-regulation of SKP2 by Notch signaling enhances proteasome-mediated degradation of the CKIs, p27Kip1 and p21Cip1, and causes premature entry into S phase. Silencing of SKP2 by RNA interference in G1 stabilizes p27Kip1 and p21Cip1 and abolishes Notch effect on G1-S progression. Thus, SKP2 serves to link Notch1 activation with the cell cycle machinery. This novel pathway involving Notch/SKP2/CKIs connects a cell surface receptor with proximate mediators of cell cycle activity, and suggests a mechanism by which a known physiologic mediator of cell fate determination interfaces with cell cycle control. |
---|---|
Bibliography: | Abbreviations used: ATRA, all-trans-retinoic acid; CDK, cyclin-dependent kinase; CKI, cyclin-dependent kinase inhibitor; ΔE, intracellular with transmembrane domain of Notch; Dll, Delta-like; EMSA, electrophoretic mobility shift assay; GSI, γ-secretase inhibitor; ICN, intracellular domain of Notch; IP, immunoprecipitation; J1, Jagged1; J2, Jagged2; N1, Notch1; N1AS, N1 antisense; Notchic, Notch intracellular domain; SCF, SKP1/CUL1/F-box; siRNA, small interfering RNA; SKP2, S phase kinase–associated protein 2. CORRESPONDENCE Nadia Carlesso: carlesso.nadia@mgh.harvard.edu |
ISSN: | 0022-1007 1540-9538 |
DOI: | 10.1084/jem.20050559 |